Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 11 - 01    source : Www.biospace.com    save search
Apollo Endosurgery Announces Publication of a Multicenter Study of Its X-Tack(R)Endoscopic HeliX Tacking System
Published: 2021-11-01 (Crawled : 20:00) - biospace.com/
APEN | $10.0 0.75% 1.7M twitter stocktwits trandingview |
Health Technology
 | | O: 0.1% H: 1.94% C: 1.26%
NextCure to Host Virtual Oncology Pipeline Update Event on November 15, 2021
Published: 2021-11-01 (Crawled : 20:00) - biospace.com/
NXTC | $1.595 1.59% 24K twitter stocktwits trandingview |
Health Technology
 | | O: 0.85% H: 4.58% C: 3.98%
Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis
Published: 2021-11-01 (Crawled : 20:00) - biospace.com/
AUPH | $4.915 2.18% 560K twitter stocktwits trandingview |
Health Technology
 | | O: -3.26% H: 4.59% C: 1.97%
treatment lupkynis results lupus
Chimerix to Present at Credit Suisse 30th Annual Healthcare Conference
Published: 2021-11-01 (Crawled : 20:00) - biospace.com/
CMRX | $0.884 -5.18% 170K twitter stocktwits trandingview |
Health Technology
 | | O: 0.19% H: 4.38% C: 4.0%
conference
LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021
Published: 2021-11-01 (Crawled : 20:00) - biospace.com/
LNSR | $3.05 -2.87% 3.8K twitter stocktwits trandingview |
Health Technology
 | | O: -0.7% H: 4.93% C: 0.99%
financial results results
ATEC to Participate in Upcoming Investor Conferences
Published: 2021-11-01 (Crawled : 20:00) - biospace.com/
ATEC | $12.59 2.03% 420K twitter stocktwits trandingview |
Health Technology
 | | O: -0.26% H: 6.5% C: 4.7%
conference
F-star Therapeutics to Announce Third Quarter Results and Host Conference Call on November 10, 2021
Published: 2021-11-01 (Crawled : 20:00) - biospace.com/
FSTX | $7.12 0.0% 0 twitter stocktwits trandingview |
Health Technology
 | | O: -0.15% H: 5.19% C: 2.82%
results conference
Science 37 to Report Third Quarter 2021 Financial Results on November 15, 2021
Published: 2021-11-01 (Crawled : 20:00) - biospace.com/
SNCE | $5.75 0.26% 49K twitter stocktwits trandingview |
| Email alert Add to watchlist
financial results results
Eledon Pharmaceuticals to Release Third Quarter Financial Results on Thursday, November 11, 2021Management to host conference call and webcast at 4:30 pm ET
Published: 2021-11-01 (Crawled : 20:00) - biospace.com/
ELDN | $1.82 -8.54% 320K twitter stocktwits trandingview |
Manufacturing
 | | O: 0.0% H: 2.4% C: 1.4%
financial results results conference
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2021 Financial Results on November 8th
Published: 2021-11-01 (Crawled : 20:00) - biospace.com/
AVDL | $17.55 0.98% 620K twitter stocktwits trandingview |
Health Technology
 | | O: -0.62% H: 4.04% C: 1.45%
financial results results
NuVasive to Present at Credit Suisse 30th Annual Healthcare Conference
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
NUVA | $39.75 -2.24% -2.29% 0 twitter stocktwits trandingview |
Health Technology
 | | O: 0.92% H: 2.27% C: 1.43%
conference
Lilly to Participate in Bernstein's Second Annual Operational Decisions Conference
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M twitter stocktwits trandingview |
Health Technology
 | | O: 0.18% H: 0.0% C: 0.0%
conference
Cocrystal Pharma Submits Pre-Investigational New Drug Briefing Package to the FDA for Clinical Development Guidance of CDI-45205 for COVID-19 Treatment
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
COCP | $1.495 1K twitter stocktwits trandingview |
Health Technology
 | | O: 3.12% H: 3.26% C: 2.72%
covid new drug treatment fda drug
Theseus Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for THE-630, a Pan-Variant KIT Inhibitor in Development for the Treatment of Gastrointestinal Stromal Tumors (GIST)
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
THRX | $4.06 0.49% 0 twitter stocktwits trandingview |
| | O: 1.05% H: 2.6% C: -0.98%
new drug fda clearance treatment fda application test gastrointestinal drug clearance
Calithera Presents Interim Data from Phase 1b Trial of Arginase Inhibitor CB-280 in Cystic Fibrosis at NACFC 2021
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
CALA | $0.04 5.3K twitter stocktwits trandingview |
Health Technology
 | | O: 2.07% H: 3.55% C: 1.52%
fibrosis phase 1 phase 1b trial phase 2b cystic fibrosis
Algernon Pharmaceuticals Establishes 6 hours as Optimum Treatment Period for DMT in Neuron Study
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
AGNPF | $0.0708 1.3K twitter stocktwits trandingview |
Health Technology
 | | O: -4.6% H: 5.49% C: 4.83%
treatment
BioVie Announces the Appointment of a New Chief Medical OfficerDr. Joseph M. Palumbo, Distinguished Pharma Industry Veteran, to Oversee Development Programs in Neurodegenerative and Liver Disease
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
SNYNF | News | $92.7 600K twitter stocktwits trandingview |
Health Technology
 | | O: 3.72% H: 0.0% C: 0.0%
JNJ | News | $147.17 0.98% 3.2M twitter stocktwits trandingview |
Health Technology
 | | O: 0.24% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M twitter stocktwits trandingview |
Health Technology
 | | O: 0.79% H: 1.18% C: 0.92%
BIVI | News | $0.4931 0.96% 330K twitter stocktwits trandingview |
Health Technology
 | | O: 1.47% H: 8.86% C: 6.28%
disease liver disease neurodegenerative liver
Akebia Therapeutics Appoints Ron Frieson, Healthcare Operations Leader, to Board of Directors
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
T | $16.35 0.12% 19M twitter stocktwits trandingview |
Communications
 | | O: 0.79% H: 0.47% C: -0.35%
AKBA | $1.345 -3.24% 1.7M twitter stocktwits trandingview |
Health Technology
 | | O: 1.74% H: 7.19% C: 7.19%
Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 Gangliosidosis
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
SIOX | $0.478 -20.5% 40K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 6.28% C: 6.28%
fda fda fast track gene therapies fast track gene therapy therapy fast track designation designation
Cabaletta Bio Reports Clinical Data from the Third Dose Cohort in DesCAARTes™ Trial in Patients with mPV
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
CABA | $13.68 -2.08% 230K twitter stocktwits trandingview |
Health Technology
 | | O: 3.15% H: 4.61% C: 1.91%
trial
Gainers vs Losers
74% 26%

Top 10 Gainers
AGBA | News | $1.27 217.5% 120M twitter stocktwits trandingview |
Finance
EGOX | $0.054 50.0% 290M twitter stocktwits trandingview |

INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals
NVFY | $2.71 28.44% 31M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.86 28.28% 29M twitter stocktwits trandingview |
Commercial Services
BSFC | $0.0822 27.64% 75M twitter stocktwits trandingview |
Manufacturing
RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a
CHRO | $1.53 24.9% 100K twitter stocktwits trandingview |
n/a
HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals
INSG | $2.98 23.14% 190K twitter stocktwits trandingview |
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.